Howard S Hochster/X
Jan 26, 2025, 14:56
Howard S Hochster: Interesting phase 3 data on intraperitoneal therapy from China
Howard S Hochster, Associate Director for Clinical Research at Rutgers Cancer Institute of New Jersey, shared a post on X:
“Interesting phase 3 data on intraperitoneal therapy from China GI25. Soon to be studied in EAONC STOPGAP study. Study lead by Dr Brett Ecker, Rutgers Cancer Institute soon.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 25, 2025, 16:56
Feb 25, 2025, 15:10
Feb 25, 2025, 14:12
Feb 25, 2025, 14:04
Feb 25, 2025, 13:56
Feb 25, 2025, 13:46
Feb 25, 2025, 13:38